TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2025
Back to search
Official data from USPTO
LONGBOARD PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LONGBOARD PHARMACEUTICALS
ST13
US500000090232106Class
5, 42, 44
Filing
90232106
Registration
6761471
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
06/22/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
10/02/2020
Registration date
06/14/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2022
Last transaction
06/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/10/2022
First use in commerce
03/10/2022
Drawing code
4
Owner type
03
Owner location
LA JOLLA, CA
Examiner
GALBO, AMANDA
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LONGBOARD PHARMACEUTICALS, INC.
Arena Pharmaceuticals, Inc.
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system
Class 42
Scientific and technological servicesmedical researchscientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical and biomedical research services; scientific research in the fields of pharmaceutical preparationsclinical trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticalsbiomedicine and clinical trials; research and development services in the fields of pharmaceuticals and biotechnology; scientific research and development; laboratory researchscreeningevaluationdevelopment and clinical testing of therapeutic compounds; scientific researchstudiesdevelopment in the field of pharmaceuticals; scientific research and developmentpharmaceutical discoveryprocess development relating to synthesis and scalability for active pharmaceutical ingredientslarge scale synthesis of active pharmaceutical ingredientsformulation development
Class 44
Providing medical information
Publications
History of USPTO decisions and trademark events.
37 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/17/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/17/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/14/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/10/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/08/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/05/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/04/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/04/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/02/2022
IUAF
USE AMENDMENT FILED
04/18/2022
EISU
TEAS STATEMENT OF USE RECEIVED
04/18/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/25/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/25/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/25/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/01/2021
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/04/2021
GPRA
PRIORITY ACTION E-MAILED
03/04/2021
CPRA
PRIORITY ACTION WRITTEN
03/04/2021
DOCK
ASSIGNED TO EXAMINER
03/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2020
NWAP
NEW APPLICATION ENTERED
10/06/2020
Continuous trademark protection
Get notified about every new filing that threatens LONGBOARD PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.